These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. What Is Optimal Front-Line Therapy for Chronic Lymphocytic Leukemia in 2017? Voorhies BN; Stephens DM Curr Treat Options Oncol; 2017 Feb; 18(2):12. PubMed ID: 28243993 [TBL] [Abstract][Full Text] [Related]
10. Chronic lymphocytic leukemia (CLL) treatment: So many choices, such great options. Sharma S; Rai KR Cancer; 2019 May; 125(9):1432-1440. PubMed ID: 30807655 [TBL] [Abstract][Full Text] [Related]
11. Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia. Griggio V; Perutelli F; Salvetti C; Boccellato E; Boccadoro M; Vitale C; Coscia M Front Immunol; 2020; 11():594556. PubMed ID: 33312177 [TBL] [Abstract][Full Text] [Related]
12. Novel Therapies for Chronic Lymphocytic Leukemia: A Canadian Perspective. Owen C; Assouline S; Kuruvilla J; Uchida C; Bellingham C; Sehn L Clin Lymphoma Myeloma Leuk; 2015 Nov; 15(11):627-634.e5. PubMed ID: 26416145 [TBL] [Abstract][Full Text] [Related]
13. Management of elderly and unfit patients with chronic lymphocytic leukemia. Mauro FR; Salaroli A; Caputo MD; Colafigli G; Petrucci L; Campanelli M; Ferretti A; Guarini AR; Foà R Expert Rev Hematol; 2016 Dec; 9(12):1165-1175. PubMed ID: 27796157 [TBL] [Abstract][Full Text] [Related]
14. Prognostic markers and standard management of chronic lymphocytic leukemia. Stilgenbauer S Hematology Am Soc Hematol Educ Program; 2015; 2015():368-77. PubMed ID: 26637745 [TBL] [Abstract][Full Text] [Related]
15. How to Choose the Best Treatment and Testing for Chronic Lymphocytic Leukemia in the Tsunami of New Treatment Options. Yeung CCS; Shadman M Curr Oncol Rep; 2019 Jul; 21(8):74. PubMed ID: 31327069 [TBL] [Abstract][Full Text] [Related]
16. State-of-the-Art Treatment and Novel Agents in Chronic Lymphocytic Leukemia. Cramer P; Hallek M; Eichhorst B Oncol Res Treat; 2016; 39(1-2):25-32. PubMed ID: 26890007 [TBL] [Abstract][Full Text] [Related]
18. Use of minimal residual disease assessment in the treatment of chronic lymphocytic leukemia. Owen C; Christofides A; Johnson N; Lawrence T; MacDonald D; Ward C Leuk Lymphoma; 2017 Dec; 58(12):2777-2785. PubMed ID: 28509580 [TBL] [Abstract][Full Text] [Related]
19. [News in therapeutic management of chronic lymphoid leukemia]. Michallet AS; Salles G; Coiffier B; Michallet M Bull Cancer; 2005 Mar; 92(3):249-56. PubMed ID: 15820919 [TBL] [Abstract][Full Text] [Related]
20. Predictive and prognostic biomarkers in the era of new targeted therapies for chronic lymphocytic leukemia. Rossi D; Gerber B; Stüssi G Leuk Lymphoma; 2017 Jul; 58(7):1548-1560. PubMed ID: 27808579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]